CLSD icon

Clearside Biomedical

53 hedge funds and large institutions have $10.2M invested in Clearside Biomedical in 2022 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 9 increasing their positions, 15 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
-1
Holders Change %
-1.85%
% of All Funds
0.86%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
12
Increased
9
Reduced
15
Closed
12
Calls
$229K
Puts
$59K
Net Calls
+$170K
Net Calls Change
+$167K
Name Holding Trade Value Shares
Change
Shares
Change %
Citigroup
51
Citigroup
New York
$842 +$41 +37 +5%
Wells Fargo
52
Wells Fargo
California
$446 +$10 +9 +2%
Marshall Wace
53
Marshall Wace
United Kingdom
-$173K -152,671 Closed
Simplex Trading
54
Simplex Trading
Illinois
-$27K -24,458 Closed
T. Rowe Price Associates
55
T. Rowe Price Associates
Maryland
-$27K -23,200 Closed
Balyasny Asset Management
56
Balyasny Asset Management
Illinois
-$25K -22,443 Closed
Goldman Sachs
57
Goldman Sachs
New York
-$22K -19,308 Closed
PAG
58
Private Advisor Group
New Jersey
-$17K -14,900 Closed
UBS Group
59
UBS Group
Switzerland
-$5K -4,599 Closed
Group One Trading
60
Group One Trading
Illinois
-$3K -2,648 Closed
TRCT
61
Tower Research Capital (TRC)
New York
-$2K -2,440 Closed
CUAMC
62
China Universal Asset Management Company
China
-$1K -563 Closed
Federated Hermes
63
Federated Hermes
Pennsylvania
-$1K -69 Closed